ライフサイエンスコーパス: crossover design

1 nmol or 1150 mg) amounts of sodium for 30 d (crossover design).

2 pram (10 mg) intravenously in a double-blind crossover design.

3 udy was a randomized controlled trial with a crossover design.

4 ate occasions in a double-blind, randomized, crossover design.

5 ented to 98 healthy subjects in a randomized crossover design.

6 diet versus a LOWCAL diet using a randomized crossover design.

7 K561679 (high-GSK), and 1 mg alprazolam in a crossover design.

8 ing after short-term SSRI exposure by a case-crossover design.

9 -5 (BACE inhibitor) or vehicle in a four-way crossover design.

10 over two separate 56-h sessions in a random crossover design.

11 lic syndrome patients following a randomized crossover design.

12 scanned repeatedly in a placebo-controlled, crossover design.

13 TANOC and (68)Ga-DOTATATE using a randomized crossover design.

14 ch (hyperhedonia) using functional MRI and a crossover design.

15 8 days apart using a randomised double-blind crossover design.

16 ndomized, counter-balanced, within-subjects, crossover design.

17 randomized, double-blind, single-dose, 4-way crossover design.

18 ia using a double-blind, placebo-controlled, crossover design.

19 olol used a double-blind, placebo-controlled crossover design.

20 ations in a double-blind, placebo-controlled crossover design.

21 acebo, on separate mornings, in a randomized crossover design.

22 condition were determined using a randomized crossover design.

23 re fed each of 3 healthy diets for 6 wk in a crossover design.

24 n MC (35% carbohydrate) diet-randomized in a crossover design.

25 sample of fifty veterans with PTSD, using a crossover design.

26 tudy used a randomized, double-masked, 2 x 2 crossover design.

27 ouble-blind, placebo-controlled, randomized, crossover design.

28 tered 3 meals in a randomized, double-blind, crossover design.

29 s for 6-wk periods according to a randomized crossover design.

30 asting and three 200% overfeeding diets in a crossover design.

31 andomized, double-blind, placebo-controlled, crossover design.

32 cording to a longitudinal, double-blind, and crossover design.

33 acebo, on separate mornings, in a randomized crossover design.

34 ed with each of 4 diets in random order in a crossover design.

35 mg) or saline in a randomized, double-blind, crossover design.

36 med by using a linear model for a two-period crossover design.

37 vehicle) every 2 weeks for 1 month each in a crossover design.

38 dapiprazole in a double-masked, randomized, crossover design.

39 ssignments were random and double blind in a crossover design.

40 ts aged 25-56 y participated in a randomized crossover design.

41 rating the treatment periods in a randomized crossover design.

42 tructured critical care elective, by using a crossover design.

43 te (HC) or high-fat (HF) diet according to a crossover design.

44 antarflexion using a prospective, randomized crossover design.

45 disease to consume black tea and water in a crossover design.

46 tmenopausal women in a 4-treatment, 4-period crossover design.

47 ets assigned by using a randomized, balanced crossover design.

48 udents completed the other scenario, using a crossover design.

49 The investigation had a randomized, blinded, crossover design.

50 rs, using a double-blind, placebo-controlled crossover design.

51 low-fiber diet for 4 wk each in a randomized crossover design.

52 iets were consumed for 23 d in a randomized, crossover design.

53 h FTFI and V-CASI techniques in a randomized crossover design.

54 ate occasions in a single-blind, randomized, crossover design.

55 a high-fat (46% fat) diet for 6 wk each in a crossover design.

56 n and nonvegetarian diets for 8 wk each in a crossover design.

57 combination with Gelofusine or saline, in a crossover design.

58 ed in 15 healthy volunteers in a randomized, crossover design.

59 cebo for 8 wk in a randomized, double-blind, crossover design.

60 dure, separated by 1 week, in a double-blind crossover design.

61 confirm this finding by using a double-blind crossover design.

62 ed two amino acid mixtures in a double-blind crossover design.

63 clinical trial performed with an open-label crossover design.

64 or low glycogen (LG) stores in a randomized crossover design.

65 at two dietary calcium intakes with use of a crossover design.

66 Seven lean, male subjects were studied in a crossover design.

67 rst or the second 15-d residency period in a crossover design.

68 high-fat and low-fat diet administered in a crossover design.

69 double-blind, placebo-controlled, randomized crossover design.

70 diet (5% of total daily energy intake) in a crossover design.

71 g pectin/d) in a prospective, single-blind, crossover design.

72 out 8 hours of nightly LBNP in a randomized, crossover design.

73 3-mm overlap, synthetic 2D mammogram) with a crossover design.

74 to intravenous ketamine in a double-blinded crossover design.

75 scle weakness, using a randomized controlled crossover design.

76 of sleep deprivation in a repeated-measures crossover design.

77 ygen uptake, 7 h rest) trial in a randomized crossover design.

78 pportunity time), according to a randomized, crossover design.

79 4 separate days with the use of a randomized crossover design.

80 e occasions in a single-blind, random order, crossover design.

81 l meal and a strawberry meal in a randomized crossover design.

82 ssions in a double-blinded pseudo-randomised crossover design.

83 g asthmatics using an open-label, randomized crossover design.

84 -30 to 240 min) in a double-blind randomized crossover design.

85 ng using a placebo-controlled, double-blind, crossover design.

86 g a double-blind placebo-controlled balanced crossover design.

87 r 0.4 mg doses) in a randomized double-blind crossover design.

88 e of a dual-center, single-blind, randomized crossover design.

89 at incorporate noninferiority, factorial and crossover designs.

90 efully consider the length of washout within crossover designs.

91 In a crossover design, 10 healthy volunteers were served beer

92 In an exploratory randomized crossover design, 10 RYGB-operated patients and 10 match

93 double-blind, randomized, repeated measures, crossover design, 11 cyclists consumed a placebo or caff

94 In a crossover design, 12 subjects with schizophrenia were st

95 In a randomized crossover design, 15 healthy volunteer consumed 100g of

96 In a placebo-controlled, within-subject, crossover design, 16 healthy human subjects performed a

97 In an open, 3-way, randomized crossover design, 18 healthy volunteers ingested felodip

98 In a crossover design, 20 healthy older men [aged 65-85 y] we

99 In a crossover design, 24 young women were provided with meal

100 mol/L, patients consumed, in a double-blind, crossover design, 250 mg caffeine or matched placebo.

101 In a crossover design, 3- to 5-y-old children in a daycare ce

102 In a double-blind, placebo-controlled, crossover design, 30 CHR-P males were studied using pseu

103 In a double-blind, randomized, crossover design, 30 healthy subjects performed two iden

104 Utilizing a double-blind, placebo-controlled crossover design, 35 fathers and their 5-month-old infan

105 Using a crossover design, a 12-hr pharmacokinetic study was then

106 were studied on 3 occasions in a randomized, crossover design after 6 d of dietary intervention.

107 The 3-period crossover design allowed for meaningful and efficient co

108 ns in clinical trial design such as parallel crossover design, alternative endpoints, or adaptive tri

109 l studies-3 with a randomized, double-masked crossover design and 1 with 4 parallel crossover studies

110 patients and 327,179 IS patients in the case-crossover design and 117,655 MI patients and 298,757 IS

111 We used a case-crossover design and 2013-2017 Mississippi Medicaid admi

112 We used a triple-crossover design and a composite of three outcomes (exac

113 Case-crossover design and conditional logistic regression to

114 All experiments used the same crossover design and followed similar experimental proce

115 The study had a crossover design and included 43 healthy men aged 19-56

116 We used a crossover design and thermal stimuli on uninjured skin t

117 We used a time-stratified case-crossover design, and conditional logistic regression mo

118 at six urban sites in New York State, a case-crossover design, and conditional logistic regression, w

119 reatments were administered to subjects in a crossover design, and diets contained 1 of 3 almond dose

120 /kg, 2 mg/kg) in a double-blind, randomized, crossover design, and exercise challenge was performed 4

121 A double-blind, placebo-controlled, crossover design approach was used in abstinent alcohol

122 onditions in a double-blind, random-ordered, crossover design, approximately 1 week apart.

123 -controlled case series method, and the case-crossover design, are described and summarized in tabula

124 ation was a randomized clinical trial with a crossover design at a nonprofit eye research institute.

125 tACS was applied using a sham-controlled crossover design at individualized intensity for 20 min

126 prevented LV diastolic dysfunction, and in a crossover design augmented conducted vasodilation and im

127 This study used a morning x evening light crossover design balanced by parallel-group controls, in

128 , placebo-controlled design; 2) absence of a crossover design between patient groups; 3) mean follow-

129 ng active comparators are described for case-crossover design, case-time-control design, self-control

130 Using a crossover design, children received for 1 d each porridg

131 A randomized, double-blinded and crossover design clinical trial was conducted.

132 All studies used randomized crossover design comparing CSII versus CLC during identi

133 were studied in a randomized, double-blind, crossover design comparing tryptophan depletion to a pla

134 4) were then tested twice, in a double-blind crossover design, comparing either: (1) placebo vs 10 mg

135 in a 2-drug, double-blind placebo-controlled crossover design conducted from January 21, 2009, to Sep

136 eived four breakfasts following a randomised crossover design consisting of different oils (virgin ol

137 The randomized crossover design corroborates that vALIC DBS causes symp

138 eg, randomized controlled trials, randomized crossover designs), could revolutionize the conduct of r

139 andomized, double-blind, placebo-controlled, crossover design, drug-free OCD adults (n=15) with near-

140 loric LF, LGI, and VLC diets in a randomized crossover design, each for a 4-week period of weight los

141 stradiol and progesterone in a double-blind, crossover design, each for four weeks, during continued

142 ents to one of four treatment sequences in a crossover design, each involving two 16-week treatment p

143 A double-blind 3-treatment crossover design employing a 6-day trial period with out

144 such as utilizing a randomized double-blind crossover design, enrolling participants likely to respo

145 domized to the following 7-day regimens in a crossover design: enteric-coated aspirin 100 mg twice da

146 lacebo-controlled clinical trial with a drug crossover design examined if mindfulness-meditation, as

147 We performed a balanced parallel and crossover design experiment with omnivorous common bulbu

148 In a crossover design experiment, data from 12 patients were

149 rograms/kg/min) or placebo in a double-blind crossover design experiment.

150 e 3-month periods (randomized, double-blind, crossover design), followed by 6 additional pacing-on mo

151 twice in a double-blind, placebo-controlled crossover design, following either placebo or 40-mg oral

152 They used a case-crossover design for 135 case events occurring among 125

153 e a day) or placebo given in a double-blind, crossover design for two 18-week periods.

154 outcome-indexed self-controlled (i.e., case-crossover) designs for active surveillance and evaluate

155 Properties of the case-crossover design have appeal for investigation of acute

156 In a balanced, placebo-controlled crossover design, healthy volunteers (n=20) received a c

157 In a double-blind, crossover design, hyperuricemic CHF patients were random

158 randomized, double-blind, placebo-controlled crossover design in 25 healthy volunteers (aged 18-25),

159 chips ad libitum for an afternoon snack in a crossover design in two 10-d periods.

160 ment used a double-blind, placebo-controlled crossover design in which 50 mg of oral DHEA was adminis

161 We used a modified crossover design in which one half of a fellowship class

162 A crossover design in which the treatment groups were swap

163 Our randomized crossover design included 27 healthy adults that underwe

164 A time-stratified case-crossover design incorporating conditional logistic regr

165 The case-crossover design, introduced in 1991 by Malcolm Maclure,

166 ETTING, AND PARTICIPANTS: A controlled 3-way crossover design involving 21 overweight and obese young

167 The case-crossover design is useful for assessing whether a recur

168 breakfast meals were tested in a randomized crossover design: low fiber, low fat; high fiber, low fa

169 ronic medication exposure by means of a case-crossover design may result in an upward-biased odds rat

170 In 2 experiments with crossover designs, men and women were served a meal of a

171 dental research application, the equivalence/crossover design methodology is shown to be an efficient

172 Using a randomized crossover design, National Survey of Family Growth (NSFG

173 In a 2-way crossover design, nonresponders (n=41) and responders (n

174 double-blind, placebo-controlled, randomized crossover design, nontreatment seeking smoking participa

175 DESIGN, STUDY, AND PARTICIPANTS: A case-crossover design of 13,860 Medicare patients with AMI fr

176 We replicated the traditional crossover design of nutrition studies in a naturalistic

177 alance and kinetic modeling in a randomized, crossover design of three 1-mo controlled dietary interv

178 In a randomized crossover design, one study was performed with each form

179 randomization or change in dose assignment, crossover design, or protocol amendment, were included.

180 In a crossover design outpatient study, 12 adults aged 24-36

181 by active AMPH in a randomized, double-blind crossover design over 4 test days.

182 With the use of a crossover design, over 2 periods we served the same 5 da

183 Unexpectedly, ketamine's effects within the crossover design showed significant (p<0.005) carryover

184 In a double-blind, order-balanced, crossover design, six healthy, trained men (normoxic VO2

185 A crossover design study in 16 men compared fasting and po

186 naurally in a planned comparison, randomized crossover design study with binaural broadband hearing i

187 randomized double-blinded placebo-controlled crossover design study, 12 patients received either a si

188 , or placebo in a double-blind, four-period, crossover design study.

189 y subjects (30 females) participated in this crossover design study.

190 dults in a double-blind, placebo-controlled, crossover designed study and then assessed memories of c

191 ects completed a randomized, double-blinded, crossover-design study in which they consumed either 5 o

192 ere randomized into a 16-week, double-blind, crossover-design study of clomipramine, a potent seroton

193 andomized, placebo-controlled, double-blind, crossover-design study.

194 This randomized crossover-designed study tested the biological activity

195 uglycemic clamping (low FFA) in a randomized crossover-designed study.

196 In a crossover design, subjects consumed diets that supplied

197 In a crossover design, subjects undertook the alternate diet

198 e the treatment response objectively and the crossover design that allows estimating the treatment ef

199 We used a randomized crossover design that consisted of a 14-d fully controll

200 Next, using a within-subject, crossover design, the authors sampled CSF for 6 hours th

201 In a double-blind placebo-controlled crossover design, the immune system in 22 sample donors

202 In a randomized crossover design, the other labeled meal, which containe

203 In the context of the crossover design, there was no statistically significant

204 Using a within-subject crossover design, this fMRI study examined how exercise

205 ese participants were randomly assigned in a crossover design to 2 periods of a 4-wk hypocaloric diet

206 in cornstarches were fed for 14 wk each in a crossover design to 24 men [10 control, 14 hyperinsuline

207 age-matched volunteers were randomized in a crossover design to 3-hour 3-OHB or placebo infusion.

208 tion fraction: 37+/-3%) were randomized in a crossover design to 3-hour of 3-OHB or placebo infusion.

209 We used a time-stratified case-crossover design to analyze all pediatric, psychiatric E

210 This study used a prospective nested case-crossover design to compare the risk of ICD shock for VT

211 descent (n = 53) were randomly assigned in a crossover design to consume a Mexican or US diet for 24

212 aging in a double-blind, placebo-controlled, crossover design to determine how intranasally administe

213 We used the case-crossover design to determine whether apneas and/or hypo

214 nistered in a randomized, placebo-controlled crossover design to eight type 2 diabetic subjects and s

215 We used a time-stratified case-crossover design to estimate adjusted odds ratios for th

216 1992 through 2006 in a time-stratified case-crossover design to estimate the association between hos

217 rsal T cell epitope (CuMV(TT) ) using a semi-crossover design to follow vaccinated horses during a se

218 on) + /- hydrocortisone (HC) in a randomised crossover design to produce low, medium and high glucoco

219 ess test were randomized in a double-masked, crossover design to receive a titrated intravenous infus

220 , patients were randomized in a double-blind crossover design to stimulation ON or OFF for 1-month pe

221 rial used a double-blind, placebo-controlled crossover design to study 73 children and adolescents ag

222 The authors used a case-crossover design to study the association between ambien

223 Our study used a crossover design to test to what extent insulin-induced

224 A prospective time-delayed crossover design trial of GS to assess the efficacy of G

225 NA or combination therapy in an open-label, crossover design trial to assess the effects on serum li

226 ffects were consistent in parallel group and crossover design trials, and in analyses of dose-respons

227 d to memantine or placebo in a double-blind, crossover design (two 24-week treatment periods, separat

228 tion age, population health, parallel versus crossover design, type of control oil, or study quality

229 was assessed by using a time-stratified case-crossover design using 11 677 emergency medical service-

230 A time-stratified, case-crossover design using a distributed lag nonlinear model

231 d food cue processing in a repeated-measures crossover design using fMRI.

232 re administered using a randomized, blinded, crossover design via a face mask and an inspiratory dema

233 A case-crossover design was applied to identify environmental r

234 andomized comparator-controlled trial with a crossover design was conducted using the erythrocyte inc

235 A randomized crossover design was incorporated in which 20 girls [mea

236 The order of the 3-phase crossover design was not randomized and there was no bli

237 currently untested hypothesis, a randomized crossover design was used in which healthy non-smokers w

238 A case-crossover design was used that compares the drugs dispen

239 A double-blind, placebo-controlled, crossover design was used to compare addition of 5 mg of

240 A randomized, crossover design was used to compare diets enriched with

241 A case-crossover design was used to compare individual drugs di

242 A case-crossover design was used to compare the distributions o

243 A case-crossover design was used to compare the drugs dispensed

244 A randomized, crossover design was used to compare the effects of a hi

245 A randomized crossover design was used to compare the effects on midd

246 A time-stratified case-crossover design was used to estimate distributed (lag 0

247 A case-crossover design was used to estimate odds ratios (OR) f

248 A time-stratified case-crossover design was used to help control for time-invar

249 A case-crossover design was used to investigate the association

250 ouble-blind, randomized, placebo-controlled, crossover design was used to investigate whether altered

251 A case-crossover design was used to study 147,885 hospital admi

252 A single-blind, randomized, within-subject crossover design was used to study the effects of palm o

253 A randomized split-mouth crossover design was used with one quadrant of surgery i

254 A randomized, double-blind, 5-period, crossover design was used.

255 A 10-week, two-treatment period, crossover design was used.

256 A double-blind, placebo-controlled crossover design was used.

257 A single-blind randomized crossover design was used.

258 A three-period crossover design was utilised lasting 42 weeks, with thr

259 le-blind, placebo-controlled, within-subject crossover design we aimed to determine the effect of a s

260 In a randomized, counterbalanced, crossover design, we applied anodal tDCS (atDCS), cathod

261 Using case-crossover design, we compared the following exposure sta

262 double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary N

263 Using a case-crossover design, we examined the association of congest

264 Using a double-blind placebo-controlled crossover design, we pharmacologically increased synapti

265 In this open-label, multicenter trial with crossover design, we randomly assigned patients with new

266 articipants, double-blinded, sham-controlled crossover design, we recorded EEG while participants wit

267 randomized, double blind, placebo-controlled crossover design, we show that OT administration in ASD

268 Using a crossover design, we studied the effect of dialysis with

269 In a randomized, double-blind, crossover design, we studied the effects of high-dose (5

270 Here, in a randomized, counterbalanced crossover design, we subjected participants to 3 weeks o

271 r time-controlled studies with nonrandomized crossover design were selected for diabetic nephropathy.

272 gression models under a time-stratified case-crossover design were used to study the relationship bet

273 of 2 successive 4-wk periods in a randomized crossover design, where 15 adults consumed wholegrain ry

274 sly (18.4 micromol) to 6 healthy adults in a crossover design with > or =2 wk between each biotin adm

275 retention was tested in a randomized-order, crossover design with 2 concentrations of sodium-1.30 g/

276 ch diet; 5 wk/diet phase] using a randomized crossover design with 2-wk washouts between phases.

277 spitalization were investigated using a case-crossover design with 28-day exposure windows, and ORs w

278 5 human subjects were tested in a randomized crossover design with 4 breads: white-wheat bread low in

279 or a green tea extract supplement in a 3 x 3 crossover design with a 1-wk washout period in between t

280 of leptin (Wt(-10%leptin)) in a single-blind crossover design with a 2-wk washout period between trea

281 bo daily for 12 wk according to a randomized crossover design with a 4-wk washout.

282 t men were studied using a randomized 5-week crossover design with a 5-week washout period.

283 ontrolled trials have used a within-subject, crossover design with an inactive placebo as the control

284 a double-blind randomized placebo-controlled crossover design with an integrated Stop-Signal and NoGo

285 y for 1 month, compared in a random-sequence crossover design with an otherwise identical 2 h of indu

286 A time-stratified case-crossover design with conditional logistic regression wa

287 A space-time-stratified case-crossover design with distributed lag models was used to

288 a maintenance diet, they were provided in a crossover design with either a vegetarian HPWL (Soy-HPWL

289 aging study used a double-blinded randomized crossover design with low-frequency inhibition trials di

290 ouble-blind placebo-controlled, three-period crossover design with naltrexone (NTX; 25 mg OD for 2 da

291 The study used a randomized, crossover design with seven subjects.

292 y-old youth were studied in a within-subject crossover design with three 3-wk phases: baseline, incre

293 randomized, double-blind, placebo-controlled crossover design with two 4-week periods of treatment, s

294 The study was a randomized crossover design with two 8-wk treatment periods.

295 andomized, double-blind, placebo-controlled, crossover design with two separate experimental sessions

296 ouble-blind, placebo-controlled, parallel or crossover designs with benzodiazepines or zolpidem in ad

297 rasted, and comparisons between parallel and crossover designs with equivalence testing are discussed

298 ed a randomized, double-blind, double-dummy, crossover design, with 16 healthy male adults administer

299 dairy portion), respectively] for 6 wk in a crossover design, with a washout period of 4 wk.

300 We used a prospective, nested case-crossover design within the Physicians' Health Study to